Skip to main content
. 2022 Jul 15;10(7):1713. doi: 10.3390/biomedicines10071713
meta <- metacont(N.HC, Mean.HC, SD.HC, N.MCI_AD, Mean.MCI_AD, SD.MCI_AD, sm=“SMD”,
data=data, studlab=paste(Author, Year))
 
## Warning in metacont(N.HC, Mean.HC, SD.HC, N.MCI_AD, Mean.MCI_AD, SD.MCI_AD, :
## Note, studies with non-positive values for n.e and / or n.c get no weight in
## meta-analysis.
 
meta$label.e <- “HC”
meta$label.c <- “MCI_AD”
print(meta, digits=2)
 
## SMD 95%-CI %W(fixed) %W(random)
## Bjerke 2009 3.40 [2.63; 4.16] 2.5 6.9
## Mattsson 2009 1.31 [1.13; 1.49] 44.8 10.4
## Hertze 2010 1.54 [1.06; 2.01] 6.4 8.9
## Palmqvist 2012 NA 0.0 0.0
## Spencer 2019 NA 0.0 0.0
## Hansson 2006 2.68 [2.12; 3.25] 4.6 8.3
## Hansson 2007 1.66 [1.18; 2.15] 6.1 8.8
## Hampel 2004 1.95 [1.10; 2.80] 2.0 6.4
## Herukka 2007 1.43 [0.96; 1.90] 6.5 8.9
## Lanari 2009 NA 0.0 0.0
## Papaliagkas 2009 NA 0.0 0.0
## Eckerstrom 2010 0.77 [0.16; 1.38] 3.9 7.9
## Kester 2011 NA 0.0 0.0
## Seppala 2011 1.03 [0.31; 1.75] 2.8 7.2
## Buchhave 2012 2.47 [1.96; 2.98] 5.6 8.6
## Parnetti 2012 NA 0.0 0.0
## Prestia 2013 NA 0.0 0.0
## Leuzy 2015 NA 0.0 0.0
## Baldeiras 2018 1.36 [0.99; 1.74] 10.4 9.5
## Khoonsari 2019 1.51 [0.93; 2.09] 4.3 8.2
## Santangelo 2020 NA 0.0 0.0
## Eckerstrom 2020 NA 0.0 0.0
##
## Number of studies combined: k = 12
##
Number of observations: o = 1855
##
## SMD 95%-CI z p-value
## Fixed effect model 1.53 [1.41; 1.65] 24.86 < 0.0001
## Random effects model 1.73 [1.39; 2.07] 9.98 < 0.0001
##
## Quantifying heterogeneity:
## tau^2 = 0.2799; tau = 0.5291; I^2 = 83.7% [72.9%; 90.1%]; H = 2.47 [1.92; 3.19]
##
## Test of heterogeneity:
## Q d.f. p-value
## 67.35 11 < 0.0001
##
## Details on meta-analytical method:
## - Inverse variance method
## - DerSimonian-Laird estimator for tau^2
## - Hedges’ g (bias corrected standardised mean difference)